
Qpex Biopharma
Developing innovative products through novel strategies for infectious diseases.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
* | $10.0m | Grant | |
Total Funding | 000k |
Related Content
Qpex Biopharma is a biotechnology company based in San Diego, specializing in the discovery, development, and regulatory approval of anti-infective medicines. The company focuses on creating new antibiotics to combat antimicrobial resistance, a growing global health threat. Qpex Biopharma collaborates with public-private partnerships to accelerate the development and impact of its products. The company serves healthcare providers and patients, particularly those affected by drug-resistant bacterial infections. Operating in the pharmaceutical and biotechnology markets, Qpex Biopharma generates revenue through the development and commercialization of its innovative antibiotic therapies. By leveraging its deep expertise and novel strategies, the company aims to make significant, sustainable improvements in patient care across both inpatient and outpatient settings.
Keywords: antibiotics, antimicrobial resistance, drug development, biotechnology, healthcare, infectious diseases, regulatory approval, public-private partnerships, patient care, pharmaceutical.